Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Count down for Ryplazim FDA Decision!

<< Previous

Bullboard Posts

Next >>

Post by StockReddyon Apr 29, 2021 12:12am

117 Views

Post# 33088919

Count down for Ryplazim FDA Decision!

37 Days, I did not sell a single share and what about you? My average is $12 and I will be in prifit if FDA approves ryplazim and I belive this time it is going to be approved.

Good luck to all

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages